KMDA Q1 2020 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena

KMDAKamada Ltd.

$495M

Q1 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$33M+24.2% YoY

Gross Profit

$11M34.4% margin

Operating Income

$5M14.6% margin

Net Income

$5M15.7% margin

EPS (Diluted)

$0.12

QoQ Revenue Growth

+3.8%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$3M

Stock-Based Comp.

$257,000

Balance Sheet

Total Assets

$197M

Total Liabilities

$31M

Stockholders' Equity

$166M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$33M	$27M	+24.2%
Gross Profit	$11M	$11M	+2.4%
Operating Income	$5M	$5M	-6.9%
Net Income	$5M	$5M	+6.0%